HIV-1 gp120-induced lysosomal stress responses are controlled by TRPML1 redox sensors

This study demonstrates that the HIV-1 envelope glycoprotein gp120 triggers neurotoxicity and lysosomal stress by activating the redox-sensitive TRPML1 channel, which disrupts iron and redox homeostasis through glutathione depletion and subsequent ferrous iron release, thereby implicating TRPML1 as a key therapeutic target for HIV-associated neurocognitive disorders.

The Gist

The Big Picture: A Viral Trojan Horse

Imagine your brain is a bustling city, and the cells are the buildings. When a person has HIV, the virus releases a "Trojan Horse" protein called gp120. This protein sneaks into the brain cells and causes chaos, leading to memory loss and cognitive decline (a condition known as HAND).

For a long time, scientists knew this Trojan Horse caused damage, but they didn't know exactly how it broke the buildings down. This paper discovers the specific mechanism: the virus hijacks a tiny, internal "security system" inside the cell, turning it against the cell itself.

The Key Players

1. The Endolysosome (The Cell's Recycling Plant):
   Inside every cell, there is a specialized recycling center called the endolysosome. Its job is to break down trash, store nutrients, and keep the cell clean. Crucially, it also acts as a warehouse for iron. Think of it as a safe deposit box holding a specific type of iron (Fe2+) that the cell needs, but only in small, controlled amounts.

2. TRPML1 (The Redox Sensor/Security Gate):
   On the wall of this recycling plant sits a gate called TRPML1. Under normal conditions, this gate stays closed, keeping the iron safely inside the warehouse. However, this gate is special: it's a "redox sensor." That means it can smell changes in the chemical environment, specifically when there is too much "rust" (oxidative stress) or "fire" (reactive oxygen species).

3. The Reactive Species Interactome (RSI) (The Chemical Weather):
   This is a fancy term for the balance of chemicals inside the cell. It includes things like oxygen, sulfur, and nitrogen compounds. Think of this as the "weather" inside the cell. A healthy cell has a mild, sunny day. A sick cell has a storm.

The Story of the Breakdown

Here is the step-by-step chain reaction the paper describes, using our city analogy:

Step 1: The Intruder Arrives
The HIV protein (gp120) enters the cell and goes straight to the Recycling Plant (endolysosome). It starts a fire, creating a lot of "smoke" and "heat" (Reactive Oxygen Species or ROS).

Step 2: The Gate Malfunctions
The smoke (ROS) hits the Security Gate (TRPML1). Because the gate is a sensor, it mistakes the smoke for a signal to open. It swings wide open!

Step 3: The Iron Flood
Once the gate opens, the warehouse dumps its entire stock of iron (Fe2+) into the main street (the cytoplasm).

• The Problem: Iron is useful in small amounts, but in large amounts, it acts like a spark in a gas tank. It causes a massive explosion of "rust" (more oxidative stress) and damages the cell's machinery.

Step 4: The Antioxidant Failure
Normally, the cell has a fire extinguisher called Glutathione (GSH) that can soak up the iron and stop the fire. But the HIV virus also steals the fire extinguisher. It lowers the levels of Glutathione inside the recycling plant. Without this protection, the iron flood is unstoppable.

Step 5: The Vicious Cycle
The flood of iron creates even more smoke (ROS), which makes the Security Gate (TRPML1) open even wider. It's a self-amplifying loop:

• More smoke $\rightarrow$ Gate opens wider $\rightarrow$ More iron floods out $\rightarrow$ More smoke.
• Meanwhile, the cell runs out of its "shield" (Hydrogen Sulfide and Glutathione), leaving it defenseless.

Step 6: The Plant Melts
Because of this chemical storm, the Recycling Plant loses its acidity (it becomes "de-acidified"). This is like a pH balance going wrong; the enzymes inside stop working, the trash doesn't get recycled, and the proteins inside get rusted (oxidized). The cell eventually dies.

The Solution Found by the Scientists

The researchers tested a "brake" for this system. They used a drug called Ned-19 (and others) that acts like a lock for the Security Gate (TRPML1).

• What happened? When they locked the gate, the HIV protein could still enter the cell, but it couldn't force the gate open.
• The Result: The iron stayed in the warehouse. The fire didn't spread. The cell's "fire extinguishers" (Glutathione and Hydrogen Sulfide) remained intact. The cell survived.

Why This Matters

This paper is a breakthrough because it identifies TRPML1 as the specific "switch" that HIV flips to kill brain cells.

• Before: We knew HIV caused brain damage, but we didn't know which specific switch to flip to stop it.
• Now: We know that if we can develop drugs that keep the TRPML1 gate locked during an HIV infection, we might be able to stop the iron flood, protect the brain cells, and prevent the cognitive decline associated with HIV.

In short: HIV tries to break the brain by opening a floodgate of iron. This study found the lock for that gate, offering a new hope for keeping the brain safe.

Technical Summary

1. Problem Statement

HIV-1-associated neurocognitive disorders (HAND) remain a significant clinical challenge despite antiretroviral therapy, affecting approximately 50% of people living with HIV. The neuropathogenesis of HAND involves chronic neuroinflammation, oxidative stress, and neurodegeneration. A key driver is the HIV-1 envelope glycoprotein gp120, which is neurotoxic and disrupts cellular homeostasis.

Previous research established that gp120 causes:

• Increased levels of reactive oxygen species (ROS) and reactive nitrogen species (RNS).
• Disruption of the Reactive Species Interactome (RSI), a network involving ROS, RNS, reactive sulfur species (RSS), and reactive carbonyl species (RCS).
• Accumulation of ferrous iron ($Fe^{2+}$) in the cytosol and mitochondria.
• Endolysosomal dysfunction, specifically de-acidification (alkalization).

However, the specific molecular mechanism linking gp120-induced ROS to endolysosomal iron release and subsequent RSI disruption was not fully elucidated. The study hypothesizes that TRPML1 (Transient Receptor Potential Mucolipin 1), an endolysosomal cation channel known to be redox-sensitive, acts as the critical sensor and effector in this pathway.

2. Methodology

The study utilized SH-SY5Y human neuroblastoma cells and U87MG human astrocytoma cells as in vitro models.

• Stimulus: Cells were treated with recombinant HIV-1 gp120 (500 pM) to mimic physiological exposure levels found in patients.
• Pharmacological Modulation:
  • Inhibitors: ML-SI1, Ned-19, and YM201636 (TRPML1 inhibitors); Apocynin (NOX2 inhibitor); NAC and Trolox (antioxidants).
  • Activators: NAADP-AM (TRPML1 agonist).
  • Redox Modulators: Reduced glutathione (GSH), oxidized glutathione (GSSG), and N-methylmaleimide (NMM, to inhibit GSH biosynthesis).
• Genetic Manipulation: Generation of stable TRPML1 knockdown (KD) U87MG cells using shRNA.
• Measurement Techniques:
  • Flow Cytometry: To quantify cytosolic and endolysosomal $Fe^{2+}$ (using PhenGreen FL DA, LysoRhonox-1, and FerroOrange), ROS (CM-H2DCFDA), and $H_2S$ (SF7-AM).
  • Confocal Microscopy: High-resolution imaging of endolysosomes (LysoTracker) to measure:
    • Lipid peroxidation (BODIPY C11).
    • Nitric oxide (siRNO).
    • GSH (RT-AM), $H_2S$ (P3), and Sulfane sulfur (SSP4).
    • Protein cysteine oxidation (DCP-Rho1).
  • pH Measurement: Ratiometric probe LysoSensor Yellow/Blue DND-160 to assess endolysosomal acidification.
  • Western Blotting: Analysis of Ferritin H (FTH1) expression as a marker of iron overload.

3. Key Contributions

This study provides the first mechanistic link connecting gp120 neurotoxicity to TRPML1 redox activation. The authors demonstrate that TRPML1 is not merely a passive channel but an active redox sensor that drives a vicious cycle of iron release and oxidative stress.

Key mechanistic insights include:

1. TRPML1 as the Primary Effector: gp120-induced ROS directly activates TRPML1, triggering the release of stored $Fe^{2+}$ from endolysosomes into the cytosol.
2. GSH Depletion as a Trigger: gp120 depletes endolysosomal reduced glutathione (GSH). Since GSH normally buffers luminal iron and inhibits TRPML1, its depletion removes this brake, facilitating massive iron efflux.
3. RSI Disruption: The release of iron and subsequent ROS generation disrupts the entire Reactive Species Interactome within the endolysosome, leading to lipid peroxidation, nitric oxide accumulation, and a collapse of hydrogen sulfide ($H_2S$) levels.
4. De-acidification Mechanism: The redox imbalance and protein oxidation (specifically cysteine oxidation of luminal proteins like v-ATPase components) lead to endolysosomal de-acidification, further impairing organelle function.

4. Key Results

• Iron Dynamics:

  • gp120 treatment significantly decreased endolysosomal $Fe^{2+}$ (indicating release) and increased cytosolic $Fe^{2+}$.
  • These effects were blocked by TRPML1 inhibitors (ML-SI1, Ned-19, YM201) and TRPML1 knockdown.
  • Conversely, the TRPML1 agonist NAADP-AM potentiated gp120-induced iron release.
  • Ferritin H (FTH1) expression increased with gp120 treatment, confirming cellular iron overload, which was prevented by Ned-19.

• Role of Glutathione (GSH):

  • Exogenous GSH decreased basal endolysosomal $Fe^{2+}$ and blocked gp120-induced cytosolic iron spikes.
  • Inhibiting GSH synthesis (NMM) mimicked gp120 effects, increasing cytosolic iron and decreasing endolysosomal iron.
  • This confirms that gp120-induced GSH depletion is a prerequisite for TRPML1-mediated iron release.

• Redox and RSI Disruption:

  • gp120 increased endolysosomal ROS, lipid peroxidation, and nitric oxide (NO). All were significantly reduced by Ned-19.
  • gp120 decreased endolysosomal $H_2S$ and GSH levels. Ned-19 blocked these decreases.
  • Notably, gp120 increased sulfane sulfur ($H_2S_n$), a protective metabolite, but Ned-19 did not block this increase, suggesting a complex, multi-faceted RSI response.

• Protein Oxidation and pH:

  • gp120 increased the oxidation of cysteine residues on luminal proteins (detected by DCP-Rho1). This was blocked by Ned-19.
  • gp120 caused significant endolysosomal de-acidification (pH increase). This was prevented by TRPML1 inhibition (Ned-19), antioxidants (NAC, Trolox), NOX2 inhibition (Apocynin), and GSH supplementation.

• NOX2 Involvement:

  • gp120 activates NOX2 to generate ROS. Inhibition of NOX2 with Apocynin prevented endolysosomal ROS spikes and subsequent de-acidification, placing NOX2 upstream of TRPML1 activation.

5. Significance and Conclusion

The study elucidates a "vicious cycle" of neurotoxicity in HAND:

1. gp120 enters endolysosomes and activates NOX2 $\rightarrow$ ROS generation.
2. ROS depletes GSH and directly activates TRPML1.
3. TRPML1 releases $Fe^{2+}$ into the cytosol.
4. Cytosolic iron and ROS drive further oxidative stress, lipid peroxidation, and $H_2S$ depletion.
5. This leads to protein oxidation and endolysosomal de-acidification, causing organelle failure and neuronal death.

Therapeutic Implications:
The findings identify TRPML1 as a promising therapeutic target. Pharmacological inhibition of TRPML1 (e.g., using Ned-19) or strategies to restore endolysosomal GSH levels could break this cycle, restore iron/redox homeostasis, and protect neurons from gp120-induced toxicity. This offers a novel pathway for treating HAND that targets the upstream organelle dysfunction rather than just downstream symptoms.